The CoronaVac vaccine developed by Chinese pharmaceutical firm Sinovac is up to 67 percent effective in preventing symptomatic COVID-19, Chile s Ministry of Health said on Friday.
Rafael Araos, doctor and advisor to the Undersecretariat of Public Health, announced the efficacy finding during the presentation of the results of a study titled Effectiveness of the inactivated CoronaVac vaccine against SARS-CoV-2 in Chile.
The study also showed the vaccine to be up to 85 percent effective in preventing hospitalization, 89 percent effective in preventing admission to an intensive care unit, and 80 percent effective in preventing death caused by the novel coronavirus disease, said Araos.
A vaccine s efficacy is the protection it provides under real-life conditions and the results of the study were based on CoronaVac s effectiveness 14 days after the second dose, explained Araos, who is also the former head of epidemiology at the Health Ministry.
La pandemia repunta en Chile, que acumula 1,1 millones de casos y 25.177 muertes
elexpresso.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elexpresso.com Daily Mail and Mail on Sunday newspapers.
Pandemia repunta en Chile, que acumula 1.1 millones de casos y 25 mil 177 muertes
pulsoslp.com.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pulsoslp.com.mx Daily Mail and Mail on Sunday newspapers.
2021-04-17 07:35:25 GMT2021-04-17 15:35:25(Beijing Time) Xinhua English
SANTIAGO, April 16 (Xinhua) The CoronaVac vaccine developed by Chinese pharmaceutical firm Sinovac is up to 67 percent effective in preventing symptomatic COVID-19, Chile s Ministry of Health said on Friday.
Rafael Araos, doctor and advisor to the Undersecretariat of Public Health, announced the efficacy finding during the presentation of the results of a study titled Effectiveness of the inactivated CoronaVac vaccine against SARS-CoV-2 in Chile.
The study also showed the vaccine to be up to 85 percent effective in preventing hospitalization, 89 percent effective in preventing admission to an intensive care unit (ICU), and 80 percent effective in preventing death caused by the novel coronavirus disease, said Araos.